SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop 10 kV silicon-carbide power semiconductors is driving attention, with traders viewing it as technology and domestic-manufacturing validation. The reaction is broadly bullish, though some caution that the prototype awards value was not disclosed and may not generate meaningful near-term revenue.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Discussion centers on ivonescimabs clinical results and pending FDA decision: traders cite positive Phase 3 survival data versus Keytruda and results in other cancer settings, while questioning whether the China-led evidence and mixed global HARMONi survival results will be enough for approval. The upcoming HARMONi-3 readout is another major focus, with optimism about the drugs broader potential balanced by concerns over regulatory risk and possible dilution.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

The FAAs review of a 737 MAX flight-management software issue is delaying 737 MAX 10 certification, weighing on Boeing shares. Traders disagree over the significance: some view the glitch as manageable and the selloff as excessive, while others see another regulatory and execution setback for the company.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks shares surged after its Phase 3 DAYBREAK study in wet AMD met its primary goals: both candidates delivered vision results non-inferior to Eylea, and 54% of Zenkuda patients maintained disease control on six-month dosing intervals; the company plans an FDA filing for Zenkuda. Traders celebrated the results and a possible short squeeze, while others warned the sharp rally could reverse and debated potential dilution given Kodiaks funding needs.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

RDDTs weakness is being linked to uncertainty over renewal of its Google AI-data licensing deal, with traders concerned that Googles publisher-payment tests could reduce the likelihood of more favorable terms; executive share sales are another recurring worry. Bulls view the pullback as an opportunity and point to Reddits data and growth potential, while bears question whether AI monetization can offset the stocks persistent underperformance.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is drawing attention as shares slide ahead of its fiscal first-quarter results, with traders focused on whether earnings and guidance will demonstrate progress turning its AI data-center backlog into operating revenue. Bulls point to long-term AI infrastructure demand and contracted projects, while skeptics cite weak price action, limited updates, and concerns about execution and dilution.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBARs sharp rally is being tied by traders to enterprise-AI developments, including Hedera-linked participation in NVIDIAs Open Agent Safety Platform and IBM-related agent identity and cloud news. The community is largely bullish on the volume and breakout, while some question whether the move is news-driven or a short squeeze and warn of profit-taking.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

OCUL is under pressure after Kodiaks positive late-stage wet AMD results raised concerns about competition for AXPAXLI. Traders disagree on the read-through: bulls argue Kodiaks dosing data are not directly comparable and point to AXPAXLIs durability and planned NDA path, while skeptics see the results as a threat to its competitive position.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

A proposed Mesabi Metallics steel complex in Iowa is fueling concern that future capacity could intensify competition for Cleveland-Cliffs, while Hamilton production cuts and layoffs add to bearish sentiment. Traders dispute the threat, with skeptics questioning whether the project will be financed and completed and others arguing it is too far off to justify the selloff.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius award of up to a federal defense grant to expand U.S. production of high-energy batteries for drones is the main catalyst, with bullish traders viewing it as strategic validation and a path to greater capacity. Others caution that the expansion is years away and does not itself confirm customer orders or near-term revenue; the stocks sharp fade after an initial rally has fueled debate over the news immediate financial impact.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ARVN The Arvinas Inc (ARVN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $102.58, representing a +1216.87% increase from the current price of $7.79. The highest analyst price target is $120.80, and the lowest is $84.37.https://stockscan.io/stocks/ARVN/forecast

Tom Wong

Explore ARVN - Arvinas Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to 2050

Stockscan

ARVN - Arvinas Inc Stock Price Forecast 2026, 2027, 2030 to 2050

StockTwits Web

Arvinas Inc

 The Arvinas Inc (ARVN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $102.58, representing a +1216.87% increase from the current price of $7.79. The highest analyst price target is $120.80, and the lowest is $84.37.